Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CD6-C52H3 | Cynomolgus | Cynomolgus CD6 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD6-C82E3 | Cynomolgus | Biotinylated Cynomolgus CD6 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD6-H82E3 | Human | Biotinylated Human CD6 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD6-H52H7 | Human | Human CD6 / TP120 Protein, His Tag | ![]() |
![]() ![]() |
Immobilized Biotinylated Cynomolgus CD6 Protein, His,Avitag (Cat. No. CD6-C82E3) at 1 μg/mL (100 μL/well) on streptavidin precoated (0.5 μg/well) plate can bind Human ALCAM, Fc Tag (Cat. No. CD6-H5259) with a linear range of 0.3-2 ng/mL (QC tested).
The purity of Cynomolgus CD6 Protein, His Tag (Cat. No. CD6-C52H3) is more than 90% and the molecular weight of this protein is around 80-100 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Itolizumab | T-1-hT; EQ-001; T-1-h; h-T1; Bmab-600; Bmab600 | Approved | Center Of Molecular Immunology | Alzumab | India | Plaque psoriasis | Biocon Ltd | 2013-01-01 | Dermatomyositis; Lupus Erythematosus, Cutaneous; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis | Details |
This web search service is supported by Google Inc.